Harvard Bioscience Net Income 2010-2023 | HBIO

Harvard Bioscience net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Harvard Bioscience Annual Net Income
(Millions of US $)
2023 $-3
2022 $-10
2021 $-0
2020 $-8
2019 $-5
2018 $-3
2017 $-1
2016 $-4
2015 $-19
2014 $2
2013 $-2
2012 $2
2011 $4
2010 $19
2009 $7
Harvard Bioscience Quarterly Net Income
(Millions of US $)
2023-12-31 $-2
2023-09-30 $-1
2023-06-30 $-1
2023-03-31 $1
2022-12-31 $-2
2022-09-30 $-3
2022-06-30 $2
2022-03-31 $-7
2021-12-31 $1
2021-09-30 $-0
2021-06-30 $-0
2021-03-31 $-1
2020-12-31 $-1
2020-09-30 $-1
2020-06-30 $-2
2020-03-31 $-5
2019-12-31 $1
2019-09-30 $-3
2019-06-30 $-0
2019-03-31 $-2
2018-12-31 $3
2018-09-30 $-0
2018-06-30 $-1
2018-03-31 $-4
2017-12-31 $1
2017-09-30 $-0
2017-06-30 $-0
2017-03-31 $-1
2016-12-31 $-1
2016-09-30 $-2
2016-06-30 $-1
2016-03-31 $-1
2015-12-31 $-17
2015-09-30 $-1
2015-06-30 $0
2015-03-31 $-1
2014-12-31 $-0
2014-09-30 $1
2014-06-30 $1
2014-03-31 $1
2013-12-31 $-1
2013-09-30 $-1
2013-06-30 $-0
2013-03-31 $0
2012-12-31 $1
2012-09-30 $-0
2012-06-30 $1
2012-03-31 $1
2011-12-31 $1
2011-09-30 $0
2011-06-30 $1
2011-03-31 $2
2010-12-31 $2
2010-09-30 $13
2010-06-30 $2
2010-03-31 $2
2009-12-31 $4
2009-09-30 $1
2009-06-30 $0
2009-03-31 $2
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.172B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $25.506B 31.32
Bruker (BRKR) United States $10.815B 30.45
Kewaunee Scientific (KEQU) United States $0.101B 11.88